EUVIMEDEUVIMED entdecken
Crossref

Clinical Impact of Proton Pump Inhibitor and Potassium-Competitive Acid Blocker for Predicting the Curability of Endoscopic Resection in Ulcerative Early Gastric Cancer

Konomu Uno, Takaya Shimura, Shingo Inaguma, Keita Kuroyanagi, Ruriko Nishigaki, Takuya Kanno, Makiko Sasaki, Shigeki Fukusada, Naomi Sugimura, Yusuke Mizuno, Takayuki Nukui, Yuki Kojima und 5 weitere

Digestion · 2024

DOI: 10.1159/000536617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestion, 2024. Verfasst von Konomu Uno und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Proton Pump Inhibitors, Endoscopic Mucosal Resection, Stomach Ulcer. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Endoscopic diagnosis is essential for predicting the curability of early gastric cancer (EGC; R0 resection) before treatment, but the relationship between ulcerative lesions and clinical outcomes remains unclear. We aimed to investigate the effect of proton pump inhibitor (PPI) or potassium-competitive acid blocker (P-CAB) on the morphological changes of ulcerative EGCs and its relevance to the clinical outcomes.

Methods

Altogether, 143 patients with differentiated ulcerative EGC that were resected by endoscopic submucosal dissection were retrospectively identified and divided into the following two cohorts depending on their PPI/P-CAB administration status: PPI/P-CAB (n = 76) and non-PPI/P-CAB (n = 67) cohorts. Furthermore, in each cohort, the patients were further divided into the improved and unimproved subgroups based on the ulcerative changes.

Results

In the PPI/P-CAB cohort, the deep submucosal invasion and lymphovascular invasion rates were significantly higher in the unimproved subgroup than in the improved subgroup, resulting in a significantly lower R0 resection rate. Contrarily, no significant differences were found between the two subgroups in the non-PPI/P-CAB cohort. The significance of PPI/P-CAB administration was observed only in the ulcerative EGCs with open-type atrophy (R0 resection rate; improved vs. unimproved, 90.9% vs. 48.0%, p = 0.001). When the finding of improved ulcer with PPI/P-CAB administration was used as the indication of endoscopic resection in ulcerative EGCs with open-type atrophy, high sensitivity (78.9%) and accuracy (76.3%) rates for the curability were observed, which were higher than those of conventional endoscopic diagnosis alone (p = 0.021).

Conclusion

PPI or P-CAB administration might contribute to the potential selection of ulcerative EGCs, enabling endoscopic curative resection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsProton Pump InhibitorsEndoscopic Mucosal ResectionStomach UlcerHumansMaleFemaleRetrospective StudiesMiddle AgedAgedGastric MucosaTreatment OutcomeGastroscopyAdultNeoplasm InvasivenessAged, 80 and overEarly Detection of Cancer

Stichwörter der Autor:innen

Endoscopic submucosal resectionMucosal atrophyPotassium-competitive acid blockerProton pump inhibitorUlcerative early gastric cancer

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Department of Pathology, Nagoya City University East Medical Center, Nagoya, Japan.

Zitieren

APA

Uno, K., Shimura, T., Inaguma, S., Kuroyanagi, K., Nishigaki, R., Kanno, T., Sasaki, M., Fukusada, S., Sugimura, N., Mizuno, Y., Nukui, T., Kojima, Y., Tanaka, M., Ozeki, K., Kubota, E., Takahashi, S., & Kataoka, H. (2024). Clinical Impact of Proton Pump Inhibitor and Potassium-Competitive Acid Blocker for Predicting the Curability of Endoscopic Resection in Ulcerative Early Gastric Cancer. Digestion. https://doi.org/10.1159/000536617

Vancouver

Uno K, Shimura T, Inaguma S, Kuroyanagi K, Nishigaki R, Kanno T, et al. Clinical Impact of Proton Pump Inhibitor and Potassium-Competitive Acid Blocker for Predicting the Curability of Endoscopic Resection in Ulcerative Early Gastric Cancer. Digestion. 2024. doi:10.1159/000536617

BibTeX
@article{Uno2024,
  author = {Uno, Konomu and Shimura, Takaya and Inaguma, Shingo and Kuroyanagi, Keita and Nishigaki, Ruriko and Kanno, Takuya and Sasaki, Makiko and Fukusada, Shigeki and Sugimura, Naomi and Mizuno, Yusuke and Nukui, Takayuki and Kojima, Yuki and Tanaka, Mamoru and Ozeki, Keiji and Kubota, Eiji and Takahashi, Satoru and Kataoka, Hiromi},
  title = {Clinical Impact of Proton Pump Inhibitor and Potassium-Competitive Acid Blocker for Predicting the Curability of Endoscopic Resection in Ulcerative Early Gastric Cancer},
  journal = {Digestion},
  year = {2024},
  doi = {10.1159/000536617}
}
Kostenlos starten →